BEIJING (Reuters) – Sinovac Biotech’s annual production capacity of COVID-19 vaccine can reach 2 billion doses by June, a company spokesman confirmed to Reuters on Wednesday.
The figure is double its previous yearly capacity of 1 billion doses in the form of bulk ingredient which the firm had said it could reach by February.
State media the Global Times had first reported the news, citing a comment from the firm’s chief executive.
(Reporting by Roxanne Liu, Lusha Zhang and Ryan Woo; Editing by Clarence Fernandez)
